NHS England

Pharmacies to trial test for risk of oesophageal cancer

NHS England said that the “heartburn health check” could help transfer care from hospitals to the community, as part of the NHS ten-year health plan.…

Tackling the NHS drug budget: why we set up a regional collaboration for medicines value

Amid NHS financial pressures, the medicines value programme lead at the North East and North Cumbria Provider Collaborative shares its approach to setting up a strategy that supports sustainable use of medicines.…

NHS ten-year plan should result in faster medicines access, says NICE

Under the ten-year health plan, the National Institute for Health and Care Excellence and Medicines and Healthcare products Regulatory Agency will work together to speed up medicines approvals.…

Community pharmacist independent prescribers increased by one-third from 2023 to 2024, workforce survey shows

Despite the increase in qualified pharmacist independent prescribers, NHS England's survey reported regional variation in the number of them using their prescribing qualification in practice.…

Smoking cessation pill Champix returns to market four years after withdrawal over carcinogen

Manufacturer Pfizer said it had “taken steps to address the presence of nitrosamines in Champix, including lowering the levels to meet regulatory requirements”.…

Pharmacists urged to report heat-related disruption as UK heatwave set to return

A report from the UK Health Alliance on Climate Change highlighted the number of overheating incidents in NHS sites nearly doubled from 2,980 in 2016/2017 to 5,554 in 2021/2022.…

NICE recommends weekly injection for severe haemophilia B

The National Institute for Health and Care Excellence said that marstacimab is a cost-effective treatment option for severe haemophilia B but not for severe haemophilia A.…

Community pharmacies in 2024/2025 administered highest number of flu vaccinations outside of pandemic

Of the 4 million flu vaccinations delivered by community pharmacies in England during the 2024/2025 flu season, data show that 11% were administered in the most deprived areas.…

NICE recommends ‘breakthrough’ therapy for blood cancer

Belantamab mafodotin combination therapy is a second-line treatment option for multiple myeloma that could benefit around 1,500 people.…

NICE recommends mirikizumab as a treatment option for Crohn’s disease

Mirikizumab (Omvoh; Eli Lilly), which is already licensed to treat ulcerative colitis but at a lower dose, is now recommended for the treatment of moderately to severely active Crohn's disease.…